◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

AGIOS PHARMACEUTICALS, INC.

CIK: 1439222 SIC: 2834
$54.03M
Revenue
$-412.78M
Net Income
88.26%
Gross Margin
-873.87%
Op. Margin
$-679.80M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 13 annual reports available (2013 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
+ Total Revenue $54.03M $54.03M $36.50M $26.82M $14.24M - $203.20M $117.91M $94.39M $43.01M $69.89M
Revenue Growth % 0.0% 48.0% 36.1% 88.4% nan% -100.0% 72.3% 24.9% 119.4% -38.5% nan%
Cost of Revenue $6.34M $6.34M $4.17M $2.88M $1.70M - $2.81M $1.32M $1.40M - -
+ Gross Profit $47.68M $47.68M $32.33M $23.94M $12.54M - $200.39M $116.59M $92.99M $43.01M $69.89M
Gross Margin % 88.3% 88.3% 88.6% 89.3% 88.0% nan% 98.6% 98.9% 98.5% 100.0% 100.0%
Operating Expenses $526.16M $526.16M $462.24M $418.31M $403.29M $378.42M $519.35M $544.25M $456.87M $363.81M $270.88M
Research & Development $339.54M $339.54M $301.29M $295.53M $279.91M $256.97M $367.47M $410.89M $341.32M $292.68M $220.16M
Selling General & Admin $180.28M $180.28M $156.78M $119.90M $121.67M $121.44M $149.07M $132.03M $114.14M $71.12M $50.71M
+ Operating Income $-472.13M $-472.13M $-425.74M $-391.49M $-389.05M $-378.42M $-316.15M $-426.33M $-362.48M $-320.79M $-200.99M
Operating Margin % -873.9% -873.9% -1166.5% -1459.5% -2732.1% nan% -155.6% -361.6% -384.0% -745.8% -287.6%
Interest Income - - - - $12.79M $836.00K $6.61M $14.86M $16.45M $6.12M $2.51M
Other Income/Expense $1.96M $1.96M $6.49M $6.05M $6.75M $14.43M - - - - -
Income Before Tax - $-413.80M $717.97M $-352.09M $-231.80M $-356.51M $-329.31M $-301.41M - - $-198.47M
Income Tax Expense - $-1.02M $44.24M - - - - - - - -
+ Net Income $-412.78M $-412.78M $673.73M $-352.09M $-231.80M $1.60B $-327.37M $-411.47M $-346.03M $-314.67M $-198.47M
Net Margin % -764.0% -764.0% 1845.9% -1312.6% -1627.8% nan% -161.1% -349.0% -366.6% -731.6% -284.0%
Basic EPS -7.11 -7.12 11.86 -6.33 -4.23 26.55 -4.74 -6.86 nan nan nan
Diluted EPS -7.11 -7.12 11.64 -6.33 -4.23 26.55 -4.74 -6.86 nan nan nan
Basic Shares Outstanding - 58.0M 56.8M 55.7M 54.8M 60.4M 69.0M 60.0M - - -
Diluted Shares Outstanding - 58.0M 57.9M 55.7M 54.8M 60.4M 69.0M 60.0M - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Cash & Cash Equivalents $89.13M $76.25M $88.20M $139.26M $203.13M $127.44M $80.93M $70.50M $102.72M $160.75M
Inventory $32.92M $27.62M $19.08M $8.49M - $14.70M $7.33M $869.00K - -
Other Current Assets $44.13M $40.16M $35.02M $38.95M $39.84M $23.65M $24.18M $17.17M $17.49M $10.26M
Total Current Assets $942.05M $965.60M $833.84M $832.77M $1.06B $636.68M $611.70M $613.78M $445.26M $559.89M
Property Plant & Equipment $10.78M $11.68M $15.38M $22.99M $28.92M $32.29M $31.47M $24.32M $24.43M $25.34M
Other Non-current Assets $3.93M $4.72M $4.06M $3.96M $2.90M $1.12M - $238.00K $891.00K $1.61M
Total Assets $1.30B $1.66B $937.12M $1.24B $1.44B $852.95M $890.74M $858.46M $614.40M $619.09M
Accounts Payable $18.36M $16.64M $9.78M $18.62M $16.70M $26.84M $21.90M $17.88M $22.77M $17.11M
Accrued Liabilities $45.46M $46.86M $43.17M $30.35M $31.97M $60.14M $53.14M $42.15M $34.03M $32.00M
Deferred Revenue - - - - - - $10.93M $32.71M $37.84M $35.91M
Total Current Liabilities $82.21M $81.16M $67.95M $62.63M $59.83M $94.39M $92.89M $93.50M $94.94M $88.43M
Other Non-current Liabilities $90.00K $880.00K $1.16M $3.28M - - - - - -
Total Liabilities $104.11M $122.24M $126.10M $137.90M $145.76M $453.45M $250.21M $170.92M $238.89M $260.50M
Common Stock - - - - $71.00K $69.00K $68.00K $58.00K $49.00K $42.00K
Retained Earnings $-561.71M $-148.92M $-822.65M $-470.56M $-238.76M $-1.84B $-1.52B $-1.10B $-798.06M $-483.15M
Treasury Stock $802.49M $802.49M $802.49M $802.49M $802.49M - - - - -
Total Stockholders Equity $1.19B $1.54B $811.02M $1.10B $1.29B $399.50M $640.53M $687.54M $375.50M $358.59M
Total Liabilities & Equity $1.30B $1.66B $937.12M $1.24B $1.44B $852.95M $890.74M $858.46M $614.40M $619.09M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Net Income $-502.07M $-412.78M $673.73M $-352.09M $-231.80M $1.60B $-327.37M $-411.47M $-346.03M $-314.67M $-198.47M
Depreciation & Amortization - - - - - - - $8.09M $7.17M $6.43M -
Stock-based Compensation $89.96M $52.55M $42.85M $44.77M $49.30M $53.51M $75.12M $72.37M $73.36M $47.81M $42.09M
Change in Receivables $6.58M $6.47M $1.30M $604.00K $2.21M - - - - - -
Change in Inventory $10.53M $5.30M $8.54M $10.58M $8.49M - $7.37M $6.46M $869.00K - -
Change in Payables $9.00K $1.75M $6.60M $-8.73M $3.44M $1.86M $5.89M $3.72M $-5.49M $5.33M $3.50M
Operating Cash Flow $-673.08M $-372.98M $-389.84M $-296.06M $-309.48M $-407.32M $-290.76M $-370.62M $-304.42M $-285.23M $38.56M
Capital Expenditure $6.72M $4.32M $1.69M $999.00K $4.88M $5.74M $14.91M $12.17M $6.99M $4.63M $9.91M
Investing Cash Flow $681.32M $377.18M $363.44M $239.57M $243.26M $1.25B $75.75M $91.44M $-273.82M $-57.91M $-119.35M
Stock Issued - - - - - - - $277.20M $516.21M $270.25M $162.15M
Stock Repurchased - - - - - $802.49M - - - - -
Financing Cash Flow $11.98M $8.68M $14.44M $5.43M $2.35M $-765.77M $261.52M $289.61M $546.02M $285.11M $169.78M
Net Change in Cash $20.22M $12.88M $-11.96M $-51.05M $-63.87M $75.69M $46.51M $10.43M $-32.22M $-58.03M $88.99M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $12.88M - $34.06M -
Cost of Revenue $1.68M - $4.47M -
Operating Expenses $129.75M - $384.62M -
Research & Development $86.80M - $251.48M -
Selling General & Admin $41.27M - $128.67M -
Operating Income $-116.87M - $-350.55M -
Other Income/Expense $67.00K - $1.84M -
Income Before Tax $-103.43M - $-304.74M -
Income Tax Expense - - - -
Net Income $-103.43M $-96.12M $-304.74M -
Basic EPS -1.78 - -5.27 -
Diluted EPS -1.78 - -5.27 -
Basic Shares Outstanding $58.14M - $57.85M -
Diluted Shares Outstanding $58.14M - $57.85M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $92.71M $76.25M
Inventory $32.03M $27.62M
Other Current Assets $43.19M $40.16M
Total Current Assets $1.03B $965.60M
Property Plant & Equipment $10.68M $11.68M
Other Non-current Assets $3.93M $4.72M
Total Assets $1.39B $1.66B
Accounts Payable $19.55M $16.64M
Accrued Liabilities $37.22M $46.86M
Total Current Liabilities $74.76M $81.16M
Other Non-current Liabilities $90.00K $880.00K
Total Liabilities $101.38M $122.24M
Retained Earnings $-453.67M $-148.92M
Treasury Stock $802.49M $802.49M
Total Stockholders Equity $1.28B $1.54B
Total Liabilities & Equity $1.39B $1.66B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-103.43M $-96.12M $-304.74M -
Stock-based Compensation - - $38.43M -
Change in Receivables - - $920.00K -
Change in Inventory - - $4.42M -
Change in Payables - - $2.89M -
Operating Cash Flow - - $-276.76M -
Capital Expenditure - - $3.20M -
Investing Cash Flow - - $287.11M -
Financing Cash Flow - - $6.12M -
Net Change in Cash - - $16.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...